RC2S+: Remediation of Social Cognitive Impairments
RC2S+
Preliminary Validation of the RC2S+ Therapy in Schizophrenia
1 other identifier
interventional
50
1 country
1
Brief Summary
Background: Difficulties in social interactions are a central characteristic of people with schizophrenia, and can be partly explained by impairments of social cognitive processes. According to renown researchers, three to five social cognitive processes are usually altered in schizophrenia: (1) emotional processing; (2) theory of mind (ToM); (3) attributional style; and (4 and 5) social perception and knowledge. The components of social cognition appear to be related to both symptomatology and functioning in everyday life. New strategies of cognitive remediation have been recently developed to target these deficits and few meta analyses have assessed the extent to which social cognitive remediation programs have led to multiple improvements for schizophrenia patients. Overall, it seems that such therapies showed encouraging results in both patient interest and motivation, and social cognitive processes. The RC2S therapy is the first individualized and partly computerized program through which patients practice social interactions and develop social cognitive abilities with simulation techniques in a realistic environment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable schizophrenia
Started Nov 2016
Longer than P75 for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2016
CompletedFirst Posted
Study publicly available on registry
November 29, 2016
CompletedStudy Start
First participant enrolled
November 29, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2021
CompletedAugust 12, 2022
August 1, 2022
4.6 years
November 16, 2016
August 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in the HB (Hostility Bias) score
AIHQ (Ambiguous Intentions Hostility Questionnaire)
week 12
Secondary Outcomes (7)
Change from baseline in social cognitive
week 12
Change from baseline in episodic verbal learning and memory
week 12
Change from baseline in visual attention and task switching
week 12
Change from baseline in social functioning
week 12
Change from baseline in symptoms at week 12
week 12
- +2 more secondary outcomes
Study Arms (2)
RC2S+
EXPERIMENTALRC2S+ Preparation sessions (sessions 1 \& 2): * Functional Outcomes Scale - Social Cognition (ERF-CS) * Psychoeducation about social cognitive impairments * Concrete objectives Cognitive remediation (sessions 3 to 22): * Paper-and-pencil session * Simulation session * Home-based task Transfer sessions (sessions 23 \& 24): * Transfer of skills in dayly life - generalization * Assessment of the achievement of objectives
Control therapy
ACTIVE COMPARATORControl therapy Preparation sessions (sessions 1 \& 2): * Functional Outcomes Scale - Neurocognition * Psychoeducation about cognitive impairments * Concrete objectives Cognitive remediation (sessions 3 to 24): * Paper-and-pencil session * Simulation session * Home-based task
Interventions
Eligibility Criteria
You may qualify if:
- Aged 18-45 years old
- Diagnosis of schizophrenia assessed with DSM5 criteria (APA, 2013)
- French native language or education in a French school since the first year of primary school
- Consent to participate to the study and agreement of the legal guardian
You may not qualify if:
- Substance use disorder (criteria of DSM-5), except for caffeine and tobacco
- Neurologic disorders (vascular, infectious or neurodegenerative)
- Uncorrected visual deficit
- Medical drugs with cerebral or psychological effect (e.g, corticosteroids)
- Patients resistant to antipsychotic medication
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
centre de réhabilitation - Hôpital le Vinatier
Lyon, Rhône, 69006, France
Related Publications (1)
Peyroux E, Prost Z, Amado I, Graux J, Demily C, Plasse J, Franck N; RC2S Consortium. Is the Cognitive Remediation of Social Cognition (RC2S) program useful to improve social cognition and functional outcomes in people with schizophrenia? A randomized controlled trial. Psychiatr Rehabil J. 2026 Jan 12. doi: 10.1037/prj0000673. Online ahead of print.
PMID: 41525374DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
FRANCK NICOLAS, PUPH
LE VINATIER HOSPITAL BRON FRANCE
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 16, 2016
First Posted
November 29, 2016
Study Start
November 29, 2016
Primary Completion
June 30, 2021
Study Completion
December 30, 2021
Last Updated
August 12, 2022
Record last verified: 2022-08